It was about midnight in June 2022 when police officers showed up at Angela Collier’s door and told her that someone anonymously requested a welfare check because they thought she might have had a miscarriage.
NGM Bio to revert to private company as MASH potential remains unclear
Sixteen years after announcing it led NGM Bio’s $25.5 million Series A, biotech investor The Column Group now plans to take the drug development company